Haven't used Ritter Pharmaceuticals yet?
Ask AI

Ask AI about Ritter Pharmaceuticals

Generated with AI from 9 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Hans Benson
Reviews 1

I've been using the products from Ritter Pharmaceuticals for a few months now and I have to say, they are amazing! The quality is top-notch and the customer service is excellent. I would definitely recommend their products to others.

Roger Casey
Reviews 1

I am a regular customer of Ritter Pharmaceuticals and I am extremely satisfied with their products and services. The quality is always great and the customer support team is very responsive. I would highly recommend them to anyone.

Branislav Tesanovic
Reviews 1

I have been a customer of Ritter Pharmaceuticals for over two years and I must say that their services are excellent. The quality of their products is always top-notch and they are always prompt in delivering the orders. The customer support team is also very helpful and responsive. I highly recommend Ritter Pharmaceuticals to anyone in need of their products.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="ritterpharma-com" data-lang="en"></div>
More widgets

About Ritter Pharmaceuticals

Ritter Pharmaceuticals, Inc. develops novel therapeutic products, which modulate the human gut microbiome to treat inflammatory, gastrointestinal and metabolic diseases. We are discovering a new frontier in human gut health research by exploring the metabolic capacity of the gut microbiota and translating the functionality of prebiotic-based therapeutics into safe and effective applications that can have a meaningful impact on a patient’s health.

Our pipeline of novel microbiome modulators selectively increase the growth of beneficial bacteria in the colonic ecosystem and create a meaningful impact on a patient’s health. Our first therapy, RP-G28, is currently under development for the treatment of lactose intolerance and has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease that affects over 1 billion people worldwide. RP-G28 has been studied in a Phase 2 clinical trial and is a first-in-class compound.